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Abstract
 
Here it is shown that the phenotype of adult mice lacking the first enhancer (DNA hypersensi-
tive site I) and the distal promoter of the GATA-1 gene (neo
 
 
 
HS or GATA-1
 
low 
 
mutants) re-
veals defects in mast cell development. These include the presence of morphologically abnor-
mal alcian blue
 
  
 
mast cells and apoptotic metachromatic
 
  
 
mast cell precursors in connective
tissues and peritoneal lavage and numerous (60–70% of all the progenitors) “unique” trilineage
cells committed to erythroid, megakaryocytic, and mast pathways in the bone marrow and
spleen. These abnormalities, which were mirrored by impaired mast differentiation in vitro,
were reversed by retroviral-mediated expression of GATA-1 cDNA. These data indicate an
essential role for GATA-1 in mast cell differentiation.
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Introduction
 
Considerable progress has been made in recent years in our
understanding of mast cell differentiation (1, 2). Mast cells
 
derive from c-kit
 
low 
 
CD34
 
low 
 
Sca-1
 
  
 
progenitor cells,
present in the marrow and spleen (3, 4). These give rise in
vivo to c-kit
 
high 
 
CD34
 
high 
 
Sca-1
 
 
 
/
 
  
 
precursors characterized
by extensive proliferation capacity, the presence of small
cytoplasmic granules, and absent or low expression of the
receptor that binds the Fc portion of the IgE antibody
 
with high affinity (Fc
 
 
 
RI
 
 
 
; references 4 and 5). In the
mouse, mast cell precursors circulate in the fetal blood (5)
to populate the connective and mucosal tissues where they
reside throughout adult life and mature into the respective
classes of definitive connective and mucosal mast cells (1,
2), characterized by specific protease expression profiles
(6). At least two classes of mast cell progenitors have been
identified in the mouse on the basis of the colonies that
they give rise to in culture. In fact, a minority of the mixed
 
(erythroid [E],
 
*
 
 megakaryocytic [Mk], and granulocytic-
monocytic [GM]) colonies detected after 14 d of culture
contain mast cells (7), indicating that the progenitor cells
from which they derive had mast cell differentiation po-
 
tential. On the other hand, colonies composed of 
 
 
 
500
mast cells each, which presumably derive from unilineage
progenitor cells, have also been identified after 21 d of
semisolid culture stimulated with IL-3 and stem cell factor
(SCF; reference 8).
 
The molecular mechanisms underlying mast cell differ-
entiation are better detailed in vitro in liquid cultures
stimulated with IL-3 supplemented with either a fibroblast
feeder layer (9) or SCF (10, 11). Under such conditions,
mononuclear cells from the marrow (and spleen) give rise
to bone marrow–derived mast cells (BMMC), which phe-
notypically and functionally resemble mast cell precursors
purified from the connective tissues of the adult animals.
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*
 
Abbreviations used in this paper:
 
 BFU, burst-forming unit; BMMC,
bone marrow–derived mast cells; E, erythroid; EPO, erythropoietin;
GM, granulocytic-monocytic; MC-CPA, mast cell carboxypeptidase A;
Mk, megakaryocytic; PGK, phosphoglicerate kinase gene; SCF, stem cell
factor; TPO, thrombopoietin; TUNEL, terminal deoxy transferase uri-
dine triphosphate nick-end labeling.T
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In fact, BMMC are c-kit
 
high 
 
Fc
 
 
 
RI
 
  
 
cells with small alcian
blue
 
  
 
cytoplasmic granules (12) that reconstitute connec-
tive and mucosal mast cell function when transplanted
into mast cell–deficient animals (13) and mature in 21 d
into berberine sulfate
 
  
 
Fc
 
 
 
RI
 
  
 
mast cells capable of taking
up and releasing serotonin after IgE/anti-IgE stimulation
(10, 12).
Several genes have been implicated in the control of
mast cell differentiation. For some of these, specific roles
have been assigned through loss of function studies in the
mouse. For example, defective mast cell differentiation re-
sults from mutations in either SCF or its receptor, c-kit
(14), mutation of the signal transducers Jak3 (15) and
PI3K (16), mutation of the transcription factor MITF
(17), encoded by the microphtalmia locus (18), and dele-
tion of gp49B1 (19), a member of the immunoglobulin
gene superfamily.
GATA-1 (for review see reference 20) is a member of a
highly conserved family of zinc finger protein-encoding
genes that are expressed in progenitor cells as well as in E
cells, megakaryocytes, and mast cells (21–25). Genetic ap-
proaches in the mouse have been instrumental in establish-
ing a key role for GATA-1 expression in the regulation of
E, Mk, and most recently, eosinophil (26) differentiation
but have not as yet demonstrated a requirement in mast
cell differentiation. This is due to the fact that GATA-1
loss of function mutants are embryonically lethal whereas
mast cell differentiation is better studied in adult animals.
Chimeric mice derived from a mixture of normal and
GATA-1
 
null 
 
embryonic stem cells contain apparently nor-
mal numbers of mast cells deriving from the GATA-1
 
null
 
clone (27, 28). In contrast, it has been recently noted that
the connective tissue of the skin from heterozygote females
carrying a GATA-1 expression mutation (and that survive
until adulthood) contains mast cells whose granules react
with alcian blue but not with berberine sulfate, suggesting
defective mast cell maturation (29). However, both studies
fail to identify the precise contribution of the mutant stem
cell clone to mast cells differentiated in vivo, leaving the
interpretation of the results uncertain. On the other hand,
the deletion of GATA-2 has been reported to ablate mast
cell differentiation of embryonic stem cells (30) and
GATA-2, but not GATA-1, is found expressed in connec-
tive mast cells by in situ hybridization (31) and western and
RNA blotting techniques (29). Indirect evidence for a
functional role for GATA-1 in mast cell differentiation is
provided by the demonstration that both mature connec-
tive mast cells and BMMC activate GATA-1 expression
shortly after IL-3 stimulation (29) and by the presence of
GATA consensus sequences in the promoter region of
mast cell–specific genes such as carboxypeptidase A (MC-
CPA; reference 32) and the 
 
  
 
chain of the human IgE re-
ceptor (33). Furthermore, ectopic GATA-1 expression ac-
tivates the expression of the endogenous MC-CPA gene
and of the IL n-1 receptor–related T1 gene from the mast
cell–specific promoters in immortalized (32) or primary
mast cells (34), respectively. However, because the consen-
sus sequences for all of the GATA proteins are similar, the
functional role of GATA-1 expression in mast cell differ-
entiation, if any, remains uncertain.
Mice generated with a targeted deletion of upstream en-
hancer and promoter sequences of the GATA-1 gene ex-
press a reduced level of GATA-1 (35). Such animals, des-
ignated GATA-1
 
low 
 
mice, are born thrombocytopenic (36,
37) and anemic (38). The few animals that survive to
adulthood recover from their anemia (39) and have a nor-
mal life span (40). The mutation affects terminal matura-
tion of megakaryocytes by preventing their fragmentation
into pro-platelets (36, 37) and of erythroblasts by increas-
ing their apoptotic rate (39). As a consequence of these de-
fects, the hemopoietic tissues of the GATA-1
 
low 
 
mice con-
tain high levels of E/Mk progenitor cells (36–39). Here it
is shown that mast cell differentiation is also impaired in
GATA-1
 
low 
 
mice. The defect is similar to that in E and Mk
lineages (i.e., amplification of the progenitor compart-
ment, increased apoptotic rate at the precursor level, and
defective differentiation of the mature cells) and is reversed
in vitro by forced GATA-1 expression. These data provide
evidence for a direct role of GATA-1 in mast cell differen-
tiation and suggest possible similarities between the regula-
tory mechanism(s) of the E/Mk and mast cell differentia-
tion pathways.
 
Materials and Methods
 
Mice.
 
The GATA-1
 
low 
 
colony was bred at the animal facilities
of the Istituto Superiore di Sanità. Littermates were genotyped by
PCR at birth as previously described (39, 40). WBB6FA W/W
 
v
 
female mice were purchased from The Jackson Laboratory. All
the experiments were performed with sex- and age (4–6 mo)-
matched mice under protocols approved by the institutional ani-
mal care committee.
 
Tissue Sampling.
 
Blood was harvested with a capillary tube
from the retro-orbital plexus and cells from the peritoneum (peri-
toneal lavage) were collected by gently washing the peritoneal
cavity with 1 ml PBS (GIBCO BRL).
 
Histological Analysis.
 
Ears and dorsal skin samples were paraf-
fin embedded according to standard procedures. Slides of consec-
utive sections were dewaxed, rehydrated, and stained with regular
(1% in H
 
2
 
O) and acidified (0.02% in 0.25% glacial acetic acid)
toluidine blue (Multilab) and safranin-counterstained alcian blue
(kit for acid mucosubstances, pH 2.5; Bio Optica; reference 41).
Cells obtained from peritoneal lavages were cytospun onto glass
slides (Cytospin 3; Shandon) and stained with May-Grunwald/
Giemsa (Sigma-Aldrich) or alcian blue. Samples for transmission
electron microscopy were fixed in 2.5% glutaraldehyde, postfixed
in OsO
 
4
 
, and embedded in SPURR resin (Polyscience). Light
microscopy was analyzed with a Leica Light Microscope (Leica)
equipped with a Coolsnap video camera for computerized images
(RS Photometrics) while transmission electron microscopy was
performed with the EM 109 Zeiss (Oberkochen).
 
Immunohistochemical and Immunofluorescence Analysis of GATA-1
Expression.
 
For immunohistochemistry, paraffin embedded sam-
ples were cut, stained with the anti–GATA-1 monoclonal anti-
body (Santa Cruz Biotechnology, Inc.), and developed with the
Ultraystain polyvalent HRP Immunostaining kit (Ylem) as de-
scribed by the manufacturers. Immunofluorescence studies were
performed on cytocentrifuged cells fixed in 4% paraformaldehyde
for 10 min, washed in PBS, and saturated for 30 min with NETT
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gel (150 mM NaCl, 5 mM EDTA, 50 mM Tris-HCl, pH 7.4,
0.05% NP-40, 0.25% carrageenan 
 
  
 
gelatin, 0.02% NaN
 
3
 
). Slides
were incubated first with the anti–GATA-1 antibody (10 
 
 
 
g/ml
NET gel) for 1 h, and then washed with NET gel and incubated
for 45 min with FITC-conjugated anti–rat IgG antibody (1:50 in
NET gel; Santa Cruz Biotechnology, Inc.). After several washes,
slides were mounted in glycerol-DABCO containing 5 
 
 
 
g/ml
4–6,diamidino-2-phenyldol (Sigma-Aldrich) to counterstain the
nuclei. Cells not incubated with the primary antibody served as
negative controls.
 
Terminal Deoxy Transferase Uridine Triphosphate Nick-end Labeling
(TUNEL) Staining.
 
TUNEL reaction was performed on paraf-
fin sections dewaxed, rehydrated, and incubated with the In Situ
Cell Death Detection Kit (Boehringer) as described by the manu-
facturer. At the end, slides were counterstained with propidium
iodide (Sigma-Aldrich).
 
Flow Cytometry Analysis and Mast Cell Purification.
 
For flow
cytometric analysis, cells were suspended in Ca
 
2
 
  
 
Mg
 
2
 
 
 
–free PBS
supplemented with 1% (vol/vol) bovine serum albumin, 2 mM
EDTA, 0.1% NaN
 
3
 
, and labeled with PE-conjugated anti–c-Kit
(CD117), anti-CD45R/B220, TER-119, and FITC-conjugated
anti-CD34, SCA-1 (all from BD Biosciences), and 2D5 (pro-
duced in the laboratory) monoclonal antibodies. To analyze the
expression of Fc
 
 
 
RI, cells were first incubated with a monoclonal
mouse anti–DNP-IgE (10 
 
 
 
g/ml, clone SPE-7; Sigma-Aldrich)
and then washed and incubated with FITC-conjugated rat anti–
mouse IgE (
 
 
 
IgE; reference 12). All antibodies were incubated
for 30 min on ice at a concentration of 1 
 
 
 
g/10
 
6 
 
cells. Cell fluo-
rescence was analyzed with the Coulter Epics Elite ESP cell sorter
(Beckman Coulter). Appropriate fluorochrome-conjugated iso-
type controls were used to gate nonspecific fluorescent signals and
dead cells were excluded by propidium iodide staining. Mast cells
were purified from B cell immuno-depleted peritoneal lavage by
sorting. First, peritoneal cells were incubated with FITC-conju-
gated CD45R (
 
 
 
1 
 
 
 
g/10
 
6
 
 cells, B220; BD Biosciences) for 30
min on ice, washed twice with PBS, and suspended in 90 
 
 
 
l
buffer and 20 
 
 
 
l MACS microbeads conjugated with a monoclo-
nal mouse anti–fluorescein antibody (Miltenyi Biotec). This cell
suspension was loaded on a MS
 
 
 
/RS
 
  
 
MiniMacs column placed
in a MACS separator. B220
 
  
 
cells were recovered in the effluent
fraction and incubated with PE c-kit for 30 min on ice. The c-
kit
 
high 
 
fraction was then sorted with the Coulter Epics Elite. The
purity of the sorted fractions was evaluated by reanalysis of the
fluorescent cells. Negative controls were represented by cell ali-
quots concurrently incubated with irrelevant isotype-matched
antibodies.
 
Progenitor Cell Counts.
 
The frequency of progenitor cells was
determined by plating light density (P 
 
  
 
1.080) marrow and
spleen cells (0.25–1.0 
 
  
 
10
 
5 
 
cells/plate) or 10 
 
 
 
l blood in stan-
dard methylcellulose culture (0.9% wt/vol) containing FBS (30%
vol/vol; Sigma-Aldrich) and a combination of recombinant
growth factors including 100 ng/ml SCF, 10 ng/ml IL-3 (Sigma-
Aldrich), 2 U/ml erythropoietin (EPO; Boehringer), and 50 ng/
ml thrombopoietin (TPO; reference 39). Cultures were incu-
bated at 37
 
 
 
C in a humidified incubator containing 5% CO
 
2 
 
in air
and scored after 7 d for burst-forming unit (BFU)-E–, CFU-
GM–, and mixed (E, Mk, and GM) CFU–derived colonies ac-
cording to standard morphological criteria. These scoring criteria
were confirmed by harvesting each colony with a glass microcap-
illary and individually transferring the colonies on glass slides for
May-Grunwald/Giemsa staining. Alternatively, cells harvested
from colonies with similar morphology were pooled and immu-
nophenotyped as described above. The frequency of progenitor
 
cells was also established in collagen-based semisolid cultures
(Mega-Cult™-C; StemCell Technologies Inc.) as described by
the manufacturer. In brief, 10
 
5 
 
light density spleen cells or unfrac-
tionated bone marrow cells were added to the basal medium sup-
plemented with SCF, IL-3, EPO, and TPO (at the same concen-
trations described above) and gel formation was induced by
adding cold collagen solution. The mixture (0.75 ml) was dis-
pensed in duplicate wells of the Mega-Cult™-C chamber slide
and incubated for 7 d. Gels were then dehydrated, acetone fixed,
and stained with toluidine blue.
 
Culture of BMMC.
 
Marrow and spleen light density cells
(1–2 
 
  
 
10
 
5 
 
cells/ml) were cultured for up to 21 d in Iscove’s
modified Dulbecco’s medium supplemented with FBS (10% vol/
vol), 4 nmol/L glutamine, 50 U/ml penicillin, and 50 U/ml
streptomycin sulfate and then stimulated with 100 ng/ml SCF
and 10 ng/ml IL-3 as previously described (10, 11).
 
Infection with Phosphoglicerate Kinase Gene (PGK)-GATA-1 Ret-
rovirus.
 
BMMC were transduced with the retroviral vector
containing the mouse GATA-1 gene under the control of the
human PGK promoter as previously described (42). In brief,
BMMC (10
 
5 
 
cells) were cocultivated either with the GP plus
E86 producer cell line, which was derived from NIH 3T3 mo-
lecularly engineered to express viral gal/pol and ecotropic env
genes (43), or with NIH 3T3 (2 
 
  
 
10
 
6 
 
cells each), as control, in
Iscove’s modified Dulbecco’s medium supplemented with FBS
(10% vol/vol; Hyclone), 4 nmol/L glutamine, 50 U/ml penicil-
lin, 50 
 
 
 
g/ml streptomycin sulfate, 6 
 
 
 
g/ml polybrene (Sigma-
Aldrich), 10 ng/ml SCF, 10 ng/ml IL-3, 1 U/ml EPO, and 50
ng/ml TPO. 48 h later, the nonadherent cells were recovered
from the flasks and transferred in the same culture media freshly
made without polybrene and additionally analyzed 10 and 17 d
later. Because the packaging cell line produces 
 
 
 
10
 
6 
 
viral particle
per ml of culture (42), 
 
 
 
90% of the GATA-1
 
low 
 
cells incubated
for 48 h under these infection conditions expressed high levels of
GATA-1 by immunofluorescence.
 
Serotonin Release Assay.
 
Cells (10
 
6
 
/ml) were incubated for
6 h at 37
 
 
 
C with 84.0 Ci/mmol [
 
3
 
H]serotonin (5-hydroxy
[
 
3
 
H]tryptamine trifluoroacetate, 2 
 
 
 
Ci/ml; Amersham Bio-
sciences), washed twice, and incubated again (20 
 
  
 
10
 
6 
 
cells/ml)
for 1 h on ice either with the monoclonal mouse anti–DNP-IgE
(10 
 
 
 
g/ml) or with medium. After incubation, cells were washed
again, divided into aliquots (0.4 
 
  
 
10
 
6
 
cells/50 
 
 
 
L), and stimu-
lated for 15 min at 37
 
 
 
C with either medium or 2 
 
 
 
g/ml rat
monoclonal 
 
 
 
IgE (R35-72; BD Biosciences), 1 
 
 
 
g/ml DNP-
human serum albumin (Sigma-Aldrich), or 1 
 
 
 
g/ml ionomycin
(Sigma-Aldrich). Reactions were terminated with 50 
 
 l cold
Hank’s balanced salt solution. The cells were removed by centrif-
ugation and the level of [3H]serotonin in the supernatants was
measured with the Packard 1600TR liquid scintillator counter
(PerkinElmer). The total amount of [3H]serotonin incorporated
by the cells was determined by lysing nonstimulated cells with 1%
Triton X-100. The levels of serotonin released upon stimulation
were expressed as absolute counts per minute and as percent of
the total amount of [3H]serotonin incorporated (cpm in superna-
tants   cpm in cell lysate   100; reference 5).
RNA Isolation and Semiquantitative RT-PCR Analysis. Total
RNA was prepared with a commercial guanidine thiocyanate/
phenol method (Trizol; GIBCO BRL) using 20  g glycogen
(Hoffmann LaRoche Ltd.) as a carrier. 1  g total RNA was re-
verse transcribed at 42 C for 30 min in 20  l of 10 mM Tris-
HCl, pH 8.3, containing 5 mM MgCl2, 1 U RNase inhibitor,
2.5 U Moloney Murine Leukemia Virus reverse-transcriptase,
and 2.5  M random hexamers (all from PerkinElmer). Gene ex-T
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pression was analyzed by amplifying 2.5  L reverse-transcribed
cDNA in 100  l of 10 mM Tris-HCl, pH 8.3, containing 2 mM
MgCl2, dNTP (200  M each), 0.1  Ci [ 32P]dCTP (specific ac-
tivity 3,000 Ci/mmol; Amersham Biosciences), 2 U AmpliTaq
DNA polymerase, and sense and 100 nM each antisense primers
specific for  2 microglobulin (39), GATA-1 (39), GATA-2 (39),
MITF (44), MC-CPA (45), MMCP-6 (45), and MMCP-7 (46).
PCR conditions were as follows: 60 s at 95 C, 60 s at 55 C, and
60 s at 72 C for  2 microglobulin, GATA-1, and MMCP-6, and
60 s at 95 C, 60 s at 60 C, and 60 s at 72 C for GATA-2, MITF,
and MMCP-7. All of the reactions were performed using a
GeneAmp 2400 thermocycler (PerkinElmer) and analyzed in the
linear range of amplification (20–35 cycles in all of the cases).
Positive (RNA from adult marrow and 32D cells) and negative
(mock cDNA) controls were included in each experiment. 20  L
aliquots were removed from the PCR mixture after selected cy-
cles of amplification, and the amplified bands were separated by
electrophoresis on 4% polyacrylamide gel for semiquantitative
amplification analysis (47). Gels were dried using a Biorad appara-
tus (Hercules) and exposed to Hyperfilm-MP (Amersham Bio-
sciences) for 2 h at  70 C. All procedures were performed ac-
cording to standard protocols (48).
Statistical Analysis. Statistical analysis was performed by analy-
sis of variance (Anova test) using Origin 3.5 software for Win-
dows (Microcal Software Inc.).
Results
GATA-1low Mice Contain Many Mast Cell Precursors but
Normal Numbers of Morphologically Abnormal Mast Cells in
Connective Tissues and Peritoneal Lavage. Histological sec-
tions of the ears from the GATA-1low mice and their nor-
mal littermates are presented in Figs. 1 and 2. No difference
was observed between the number of mast cells revealed by
toluidine blue and alcian blue staining in the wild-type ani-
mals (Fig. 1). In contrast, in the GATA-1low animals, nu-
merous metachromatic  granule-containing cells but nor-
mal numbers of mature mast cells were detected by
toluidine blue and alcian blue/safranin staining, respec-
tively, in the connective tissue just above the middle carti-
lage (the trabeculated structure recognizable between two
skin layers at the lower level of magnification in Fig. 1 B)
of the ear (Figs. 1 and 2; reference 49). The frequency per
mm2 of total granule-containing cells in the connective re-
gion of the ear and skin from the GATA-1low mice and
from littermates was 991   226 versus 259   193 (ear) and
475   14 versus 112   18 (skin), respectively (P   0.01 in
both cases), whereas the frequency of mature mast cells in
mutants versus controls was 363   17 versus 193   70
(P   0.05) in the connective tissues of the ear and 157  
37 versus 104   15 (P   0.08) in the skin (Table I).
Similar to findings in connective tissues, peritoneal la-
vage from the mutant mice contained more metachromatic 
granule-containing cells than lavage from controls, whereas
they contained similar numbers of alcian blue  cells (Table
I). The frequencies of the two cell populations in perito-
neal lavage of the GATA-1low mice and normal littermates
was 11.2   1.4 versus 3.3   0.7 (P   0.001) and 4.4   0.4
versus 3.1   0.6 (P   0.05), respectively. Of note, al-
though dividing cells were never detected in lavages from
normal mice, dividing cells represented 0.3% of all the
granule-containing cells present in lavages of the GATA-
1low mice. The higher incidence of immature mast cells in
peritoneal lavages of the GATA-1low mice was confirmed
by FACS® determination of the frequency of cells express-
ing c-kit and Fc RI (Fig. 3 A). In lavages of both mutant
and normal mice, the majority ( 75%) of the cells were
B220  (B cells; not depicted). Lavages from the mutant
mice contained more c-kit  cells than those from normal
mice (4–6% vs. 1–2%, respectively), although the fre-
quency (and the levels of expression) of Fc RI  cells was
markedly reduced in the GATA-1low samples (30 vs. 50% of
the c-kithigh cells, respectively; Fig. 3 A).
Mast cells of the GATA-1low animals presented an abnor-
mal morphology characterized by a larger size (Figs. 1 and
2). Morphological differences were confirmed by observa-
tions under transmission electron microscopy of thin sec-
tions from the ears (Fig. 2, E and F). This analysis not only
confirmed the larger size of the mutant cells, but revealed
further abnormalities that included more disperse chroma-
tin structure and heterogeneity in size and electron density
of cytoplasmic granules (50).
To detail the molecular defects of the GATA-1low mast
cells, the levels of expression of the mast cell–specific pro-
teases MMCP-6, MMCP-7, and MC-CPA were analyzed
by semiquantitative RT-PCR in unfractionated or purified
c-kithigh cells from peritoneal lavages of GATA-1low and
normal littermates (Fig. 3 C). In agreement with the low
frequency of mast cells in the peritoneal lavages, most of
the genes investigated were not amplified from cDNA of
unfractionated cell preparations. On the other hand, all
of the genes considered were amplified from cDNA from
c-kithigh cells purified from normal peritoneal lavage (Fig. 3
C). In contrast, when cDNA from c-kithigh cells purified
from GATA-1low animals was used as template, fragments
specific for MC-CPA were never amplified and amplifica-
tion of MMCP-6 was markedly reduced. Interestingly,
GATA-2 was amplified at the same levels from c-kithigh
cells purified from both mouse strains whereas GATA-1
was amplified with cDNA from wild-type but not GATA-
1low littermates.
To confirm that the GATA-1low  mutation impaired
GATA-1 expression in mast cells, the presence of GATA-1
protein was compared in ear and peritoneal lavage cells by
immunohistochemical (Fig. 2) and immunofluorescence
(unpublished data) microscopy, respectively. GATA-1 pro-
tein was readily detectable in mast cells of the normal mice
with both techniques, but was barely detectable in GATA-
1low cells (Fig. 2, C and D).
To clarify why the connective tissues of GATA-1low
mice contained normal numbers of mature cells in spite of
their high content of mast cell precursors, the frequency of
apoptotic cells in the connective tissues was evaluated by
TUNEL staining of ear sections (Fig. 4). Very few ( 19
nuclei/mm2) fluorescent nuclei were identified in ear sec-
tions of normal mice (Fig. 4, A and C). In contrast, high
numbers of fluorescent cells (134   2/mm2) were observed
in ear sections of GATA-1low mice in which high numbersT
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of mast cells had been identified (Fig. 4, B and D). The
cells with apoptotic nuclei were positively identified as
mast cell precursors by toluidine blue staining (not de-
picted).
Hematopoietic Tissues from the GATA-1low Mice Contain
High Numbers of a “Unique” Trilineage (E-Mk-Mast Cell) Pro-
genitor Cell. It has been reported that hematopoietic tis-
sues from the GATA-1low mice contain high numbers of E
and Mk progenitor cells whereas the number of myeloid
progenitors is normal (36–39). It has also been demon-
strated that tissues of mutant mice contain a unique pro-
genitor cell, bipotent for the E and Mk lineage, which
gives rise to colonies with a typical morphology and whose
cells, once transferred into fresh medium, proliferate for at
least a couple of passages (36). Similar colonies (the mor-
phology of one of them is presented in Fig. 5 A) were also
detected in this study. However, when single colonies
were harvested from the dish and individually transferred
onto glass slides for morphological analysis, it was recog-
nized that they contained, in addition to E and Mk cells,
Figure 1. Connective tissue of
the ear of the GATA-1low mice
contains high numbers of mast
cell precursors (metachromatic 
after toluidine blue) but normal
numbers of more mature (alcian
blue  safranin ) mast cells. Tolu-
idine blue (A–D) and alcian
blue/safranin (E–H) staining of
consecutive paraffin-embedded
sections of the ear from one rep-
resentative GATA-1low  mouse
(right panels) and a wild-type
(left panels) littermate, as indi-
cated. The presence of mast cells
and their precursors is indicated
by arrows. The results are repre-
sentative of replicative analysis
from at least four mutants and
four normal mice.  10 in A, B,
E, and F and  100 in C, D, G,
and H.T
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granule-containing cells that resembled mast cell precursors
(Fig. 5 B, Mc). To exclude the possibility that such a mast
cell component represented an artifact due to cell contami-
nants picked up from the methyl-cellulose, marrow and
spleen cells from the GATA-1low mice were also cultured in
dishes made semisolid with collagen and stimulated with
the same mixture of growth factors used for the standard
cultures. After 7 d, the collagen gels were dried and stained
with toluidine blue and/or with acethyl-colinesterase. Also
in this analysis, GATA-1low, but not normal marrow and
spleen cells, gave rise in 7 d to colonies that were identified
in situ as containing erythroblasts, megakaryocytes (acethyl-
colinesterase ), and mast cells (metachromatic  granule-
containing cells; unpublished data). This unique trilineage
progenitor cell is termed CFU-EMkMc. CFU-EMkMc
were below the level of detection in marrow, spleen, and
blood cultures of normal littermates (Table II). In contrast,
they represented 65–72% of all progenitor cells present in
the marrow and spleen of GATA-1low animals (Table II).
As many as 315   65 and 800   150 CFU-EMkMc–
derived colonies were detected per 105 nucleated cells of
the spleen and marrow from GATA-1low mice. These colo-
nies were detectable at a frequency of 12   4 per  L in the
blood of the GATA-1low mice (Table II).
The cells present in the CFU-EMkMc–derived colonies
were further characterized by FACS® analysis. Cells pooled
from normal BFU-E–derived colonies were analyzed in
parallel as control (Fig. 5 C). The cells were double stained
with either TER-119/2D5 to detect E and Mk cells, or
with CD117 that recognizes c-kit and CD34 to detect mast
cell precursors. The majority of the cells pooled from the
BFU-E–derived colonies cultured from normal mice ex-
Figure 2. Connective mast
cells from the GATA-1low mice
exhibit abnormal morphology
and express lower levels of
GATA-1 than the cells of nor-
mals. Acidified toluidine blue
staining (A and B) and GATA-1–
specific immunohistochemistry
(C and D) of consecutive paraffin-
embedded sections from the skin
at the base of the ear from a
GATA-1low mouse and its nor-
mal littermate (right and left pan-
els) and transmission electron
microscopy (E and F) of the
same specimens. Negative con-
trols for the GATA-1 staining
were represented by slides incu-
bated with an irrelevant isotype-
matched antibody (not de-
picted). The presence of mast
cells and their precursors is indi-
cated by arrows. Similar results
were obtained in at least four in-
dependent analysis.  10 in A
and B,  100 in C and D and the
inserts, and  4,400 in E and F.T
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pressed, as expected, TER-119 and/or 2D5 but very few,
if any, expressed high levels of c-kit and/or CD34 (Fig. 5
C). c-kithigh and CD34high cells were also below the level of
detection in pools of CFU-GM–derived colonies obtained
from the same cultures (unpublished data). In contrast, only
some cells from the CFU-EMkMc–derived colonies ex-
pressed TER-119 and/or 2D5 whereas 16% of them coex-
pressed high levels of CD34 and of c-kit (Fig. 5 C). c-kithigh
CD34high cells were positively identified as mast cells by
sorting and May-Grunwald staining (not depicted).
To further characterize the differentiation potential of
mast cells present in the CFU-EMkMc–derived colonies,
cells pooled from these colonies (as well as cells pooled
from BFU-E– and CFU-GM–derived colonies obtained
from normal mice) were cultured in liquid culture stimu-
lated with SCF and IL-3, plus or minus a murine fibroblast
feeder layer (Fig. 6, NIH 3T3). Cells pooled from normal
BFU-E– or CFU-GM–derived colonies failed to prolifer-
Table I. Frequency of Mast Cell Precursors and Mature Mast Cells in Ear and Skin Sections and in Peritoneal Lavages of Normal and
GATA-1low Mice
Ear
(cells/mm2)
Skin
(cells/mm2)
Peritoneal lavages
(percent of total nucleated cells)
Toluidine 
blue  Alcian blue 
Toluidine 
blue  Alcian blue  May-Grunwald Alcian blue 
Normals 300 260 106 100 2.6 3.6
173 120 97 91 2.98 2.4
306 200 132 120 3.9 3.3
Mean ( SD) 259   75 193   70 112   18 104   15 3.3   0.7 3.1   0.6
GATA-1low 1,160 330 492 140 11.8a 4.6
733 306 466 200 12.2 4.6
1,080 363 470 132 9.6 3.9
Mean ( SD) 991   226 333   17 475   14 157   37 11.2   1.4 4.4   0.4
P  0.01  0.05  10 5  0.08  10 3  0.05
The results obtained from three individual GATA-1low and normal littermates are presented (each line an individual mouse).
a0.3% of the cells were in morphologically recognizable mitosis.
Figure 3. Mast cells in peritoneal lavage from GATA-1low mice express
lower levels of Fc RI and of the proteases MMCP-6 and MC-CPA than
the corresponding cells from normal littermates. (A) The FACS® analysis
of cells from peritoneal lavage from normal and GATA-1low mice stained
with PE c-kit and FITC-Fc RI is presented. Cells from the peritoneal la-
vage of the mast cells deficient W/Wv mice (reference 51) were analyzed
in parallel as negative control. The gating used for the Fc RI analysis is
shown in a representative dot plot of PE c-kit versus side scatter analysis.
Very similar c-kit/side scatter dot plots were observed in all the cases. The
isotype control for the Fc RI analysis is not shown because it is superim-
posable to the histogram obtained with cells from the W/Wv mouse. (B)
The gating used to purify c-kithigh cells from the peritoneal lavage and a
representative reanalysis after sorting of the purified cells is presented. In
all of the cases,  80% of the sorted cells were c-kithigh upon reanalysis.
The semiquantitative RT-PCR analysis for the expression of  2 micro-
globulin ( 2-MG), GATA-1, GATA-2, MMCP-6, MMCP-7, and
MC-CPA in unseparated or c-kithigh  cells of peritoneal lavage from
GATA-1low and normal littermates is presented in C. Each product was
amplified for increasing number of cycles (20, 25, 30, and 35), as indi-
cated by the triangle on the top of the panels. Similar results were ob-
tained in two additional experiments.T
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288 GATA-1 and Mast Cell Differentiation
ate and survived for 1–2 wk or less when transferred into
liquid culture (Fig. 6 E). In contrast, cells harvested at day 7
from CFU-EMkMc–derived colonies proliferated for up to
50 d under these conditions (Fig. 6 E). The high prolifera-
tive capacity was confirmed in limiting dilution experi-
ments in which single cells were deposited in 96-multiwell
plates. Cell proliferation occurred in  98% of the wells
provided that the cultures had been stimulated with both
SCF and IL-3 (unpublished data).
After the second week of liquid culture, the CFU-
EMkMc–derived cells acquired a homogeneous morphol-
ogy of granule-containing cells that coexpressed high levels
of c-kit and CD34 (Fig. 6, F and G) but did not react with
alcian blue (unpublished data). Some of the c-kit  cells co-
expressed Fc RI, although the levels of Fc RI expression
remained below those expressed by normal BMMC
throughout the time in culture (compare Fig. 6 F with 7
A). Of interest, the CFU-EMkMc–derived cells adhered
with high frequency ( 54% after overnight incubation) to
murine fibroblasts (Fig. 6) but expressed an immature phe-
notype characterized by lack of reactivity with alcian blue
(unpublished data) and low levels of Fc RI expression (Fig.
6 G). These results suggest that mast cell precursors within
the CFU-EMkMc–derived colonies are unable to com-
plete differentiation.
Differentiation of BMMC Derived from Hemopoietic Tissues
of GATA-1low Mice Is Defective In Vitro. Mast cell differen-
tiation has seldom been reported in cultures of normal mu-
rine hemopoietic tissues at day 7 (12) but many mast cell–
containing colonies were detected at this time in semisolid
cultures of tissues from the GATA-1low mice (Figs. 5 and
6). Because CFU-EMkMc represent a unique class of pro-
genitor cells found only in the tissues of the GATA-1low
mice, it is possible that the defective mast cells they contain
are the result of “abortive differentiation” under nonper-
missive culture conditions. To directly compare the matu-
ration of mast cells differentiated in vitro from normal and
GATA-1low mice, marrow (and spleen) cells were cultured
under conditions specific for the generation of BMMC (10,
12). The results obtained are presented in Fig. 7. Under
these conditions, a homogeneous population of BMMC
(95% of which were c-kithigh/Fc RIhigh) was observed after
21 d in normal cell cultures. In contrast, marrow cells from
the GATA-1low mice yielded a BMMC population, the
majority (87%) of which expressed high levels of c-kit, that
was composed both by Fc RI   (16.3%     3.7%) and
Fc RI  cells (83.7%   3.7%, P   0.001 with respect to the
frequencies observed in cultures obtained from normal
mice; Fig. 7 A). In addition, the GATA-1low BMMC ex-
pressed less Fc RI on their surface than normal cells (me-
dian fluorescence intensity 120 vs. 150 arbitrary units, re-
spectively; Fig. 7 A).
In vitro maturation of GATA-1low mast cells was ana-
lyzed further by comparing the levels of [3H]serotonin in-
corporated and released upon appropriate stimulation with
values obtained with normal BMMC (Fig. 7 B). Cells ob-
tained in 21 d of culture from tissues of GATA-1low mice
and normal littermates incorporated comparable high levels
Figure 4. Connective region
of the ear from the GATA-1low
mice contains high numbers of
apoptotic cells. TUNEL staining
of representative paraffin-
embedded sections of the ear
from wild-type (A and C) and
GATA-1low (B and D) mice, as
indicated. Negative controls
were represented by tissue sec-
tions treated with a fluorescent
deoxyuridine triphosphate-free
TUNEL reaction mixture and
are not presented for conve-
nience. Fluorescent nuclei were
not detected in negative controls
(not depicted), were rare ( 5/
mm2) in sections from the wild-
type ear (A and C), and were
numerous (134   2/mm2) in the
connective region just below the
epithelium of the sections from
the GATA-1low ear (B and D).
 10 and  40 in the top and
bottom panels, respectively.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
289 Migliaccio et al.
of [3H]serotonin. However, GATA-1low BMMC released
significantly less [3H]serotonin after IgE- IgE stimulation
than cells obtained from the normals (36   14 vs. 62   10,
respectively; P   0.01).
In addition, the protease expression profile of GATA-
1low and normal BMMC was compared by semiquantitative
RT-PCR analysis (Fig. 7 C). Although more MMCP-6
and MMCP-7 fragments were amplified with cDNA from
GATA-1low than from wild-type BMMC, MC-CPA frag-
ments were amplified only with cDNA from wild-type
cells (Fig. 7 C).
These results indicate that the GATA-1low mast cells
mature poorly in vitro even under specific culture condi-
tions.
Forced GATA-1 Expression Restores the Mast Cell Differen-
tiation Potential of GATA-1low BMMC In Vitro. To clarify
whether the defective mast cell differentiation observed in
cultures from the GATA-1low mice was a direct conse-
quence of the mutation affecting GATA-1 expression, we
examined whether reexpression of GATA-1 would restore
the in vitro maturation potential of GATA-1low BMMC.
GATA-1low cells, obtained at day 7 under BMMC-specific
conditions, were cocultured either with NIH 3T3 or with
the NIH 3T3–derived cells producing the PGK-GATA-1
virus (42). 48 h later, nonadherent cells were harvested and
transferred into fresh medium. At days 10 and 17 after in-
fection, cells were analyzed for their surface antigenic pro-
file and GATA-1 expression. The expression of mast cell–
Figure 5. Bone marrow of
GATA-1low mice contains trilin-
eage progenitor cells that give
rise to colonies composed of
erythroblasts, megakaryocytes,
and mast cells. (A) The morphol-
ogy of a trilineage colony, as
compared with that of a BFU-E–
derived colony growing in its
neighborhood is presented. The
colony was photographed at day
7 in bone marrow cultures of
GATA-1low mice stimulated with
SCF, IL-3, EPO, and TPO. (B)
May-Grunwald/Giemsa staining
of the smear of a representative
trilineage colony is presented.
Erythroid (E), megakaryocytic
(Mk), and mast (Mc) cells are in-
dicated by arrows. Similar re-
sults were observed on smears of
at least 10 additional individual
colonies.  10 and  100 in the
left and right panels, respectively.
(C) FACS®  analysis of cells
pooled from CFU-EMkMc–
derived colonies immunopheno-
typed by double staining with
TER-119/2D5 (E/Mk markers)
and c-kit/CD34 (mast cell mark-
ers) antibodies is presented. Cells
pooled from BFU-E–derived
colonies grown in the corre-
sponding cultures from normal
mice (WT-BFU-E) were immu-
nophenotyped in parallel with
the same antibodies for compari-
son. RI and RII indicate regions
of the dot plots corresponding
to the antigenic profile c-kitlow
CD34low and c-kithigh CD34high,
characteristic of progenitor cells
(reference 52) and mast cells, re-
spectively. Negative controls
were represented by cells stained
with appropriate isotype
matched irrelevant antibodies
(not depicted). Similar results
were obtained in three indepen-
dent experiments.T
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specific differentiation markers (metachromasia after tolui-
dine blue, reactivity to alcian blue and expression of MITF,
MMCP6, and MMCP7) was also analyzed.
Before infection, the cells used in these experiments
contained both E (TER-119 ) and mast cell (c-kithigh/
SCA-1 ) precursors (Fig. 8 E and unpublished data). After
coculture with the murine fibroblasts, TER-119   cells
were not detectable (unpublished data) and almost all
( 95%) of the cells grown under these conditions ex-
pressed high levels of c-kit at 10–17 d. All BMMC cocul-
tured with NIH 3T3 (mock-infected) became c-kit 
SCA-1  after 17 d whereas some (35%) of the PGK-
GATA-1–infected BMMC were SCA-1  (Fig. 8 E). Be-
cause expression of SCA-1 is lost during differentiation of
hemopoietic cells, these findings suggested that transduc-
tion with a GATA-1–containing retrovirus might have in-
duced maturation of the GATA-1low BMMC.
The morphological analysis of transduced BMMC is pre-
sented in Fig. 8. Very low levels of GATA-1 protein were
detectable by immunofluorescence in the GATA-1low
BMMC before infection (Fig. 8 A) or after coculture with
NIH 3T3 cells (not depicted). In contrast, high levels of
GATA-1 expression were expressed by  65% of the cells
that had been cocultured with the PGK-GATA-1–produc-
ing cell line (Fig. 8 B). This result indicates that the major-
ity of the GATA-1low cells being analyzed were infected by
the retrovirus. Forced GATA-1 expression resulted in
marked changes in the maturation profile of the GATA-
1low BMMC. These changes included a reduction in cell
size and the appearance of cytoplasmic alcian blue 
metachromatic  granules (Fig. 8 D). These results indicate
that forced GATA-1 expression restored the in vitro matu-
ration potential of GATA-1low BMMC.
Increased GATA-1 expression in transduced GATA-1low
BMMC was confirmed by semiquantitative RT-PCR
analysis (Fig. 7 F). Before infection, day 7 BMMC ex-
pressed GATA-1 and GATA-2, as well as the mast cell–
specific transcription factor MITF and tryptases MMCP6
and MMCP7, which represent markers for cells at earlier
and later times in BMMC-specific cultures, respectively.
(53). Mock-infected cells expressed high levels of GATA-2
and very low levels of GATA-1 whereas the levels of ex-
pression of the mast cell–specific genes remained similar to
that observed at baseline. On the other hand, cells cocul-
tured with the PGK-GATA-1 cell line expressed high lev-
els of GATA-1 whereas the levels of expression of GATA-2
increased only modestly over baseline. Of note, these cells
expressed lower levels of MMCP6 and higher levels of
MMCP7 than mock-infected cells.
Discussion
We have demonstrated that mast cell differentiation is
defective in mice harboring a targeted deletion that re-
moves upstream enhancer and promoter elements of the
GATA-1 gene. The mutation affects all stages of mast cell
differentiation. More specifically, it alters the commitment
process by inducing the formation of high numbers of a
unique class of progenitor cells (the CFU-EMkMc), in-
duces an increase in proliferation that is coupled by in-
creased cell death (but on balance generating more live cells
than dead) of the precursor cells, and finally, impairs the
expression of the Fc RI receptor and of the MC-CPA
in mature mast cells. Our findings, therefore, implicate
GATA-1 as a critical transcription factor for proper mast
cell development.
At the level of the progenitor cell compartments, the
most striking alteration was reflected by the presence of a
unique class of cells, the CFU-EMkMc, which are appar-
ently committed toward the E, Mk, and mast cell lineage
(Fig. 5). The CFU-EMkMc gave rise to colonies in only 7 d
of culture and their frequency was as high as 800   150
and 315   65 progenitor cell per 105 mononuclear bone
marrow and spleen cells, respectively (60–70% of all the
progenitor cells present in these organs). Because CFU-
EMkMc were not detected from normal mice, their rela-
tionship to the pathway of normal hemopoietic differentia-
tion is unclear. In the hierarchy of normal hemopoietic
cells, mast cell differentiation potential is thought to be lost
before the restriction toward E/Mk differentiation occurs.
In fact, mast cells are detected in single cell deposition cul-
tures of purified common myeloid progenitors and not in
those of the purified common E/Mk ones (54). It is possi-
ble, however, that reduced GATA-1 expression at the pro-
genitor cell level might alter the commitment process itself,
Table II. Frequency of Progenitor Cells in the Marrow and Spleen 
of Normal and GATA-1low Animals
Number of progenitor cells
Normal mice GATA-1low mutants P
Bone marrow
(CFU/105 cells)
BFU-E 149   33 165   33  0.01
CFU-GM 165   25 145   16  0.05
CFU-EMkMc 0 800   150  0.001
Spleen
(CFU/105 cells)
BFU-E 15   3 110   21  0.05
CFU-GM 40   5 56   16  0.05
CFU-EMkMc 0 315   65  0.001
Blood
(CFU/10  L)
BFU-E 1   1 14   3  0.05
CFU-GM 3   29     2  0.05
CFU-EMkMc 0 12   4  0.05
Results are presented as the mean ( SD) of at least four independent
experiments performed in duplicate for at least eight individual mutants
and eight normal littermates analyzed.T
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291 Migliaccio et al.
thereby allowing E/MK progenitor cells to retain mast cell
differentiation potential (55).
At the precursor level, approximately three times more
mast cells were found in the connective region of the skin
(Figs. 1 and 2) and in peritoneal lavage (Table I) of the mu-
tant mice. Conversely, granule-containing cells were ob-
served in the connective region but not in the mucosa of
the stomach (unpublished data). An increased number of
mast cell precursors might result from either increased pro-
liferation capacity and/or a block in terminal maturation.
The first possibility is supported by the presence of many
(0.3%) dividing mast cells in peritoneal lavage and the high
proliferative capacity exhibited by GATA-1low BMMC in
vitro ( 98% of which were capable to proliferate in single
cell cloning experiments). However, cultured mast cells
typically have high proliferative capacity (12) and even
normal mature cells purified from the tissues of the mice
may regain proliferative potential once induced to degran-
ulate (i.e., they are de-differentiated; reference 56). The
fact that c-kithigh FC RI  cells were still detectable after
21 d in BMMC-specific cultures seeded with marrow (and
spleen) cells of mutant origin (Figs. 6 and 7) favors the pos-
sibility that the increased proliferation is a direct result of a
block in the cellular maturation induced by the mutation.
In spite of the increased frequency of mast cell precursors
in tissues of the GATA-1low mice, the number of mature al-
cian blue  safranin  cells in the same tissues was not signifi-
cantly higher or only modestly ( 20–50%) higher than
Figure 6. Defective matura-
tion of mast cell precursors in
vitro in CFU-EMkMc–derived
colonies. Phase contrast micro-
scopic observation (A and B) and
May-Grunwald/Giemsa staining
(C and D) of CFU-EMkMc–
derived cells grown for 2 wk ei-
ther in suspension or on fibro-
blast feeder layer (on the left and
right panels, as indicated) in the
presence of SCF and IL-3.  100
in both. (E) The growth curves
of CFU-EMkMc–derived cells
(straight lines) grown for up to
45 d in cultures stimulated with
SCF and IL-3 either in suspen-
sion culture ( ) or on a fibro-
blast underlayer ( ) are pre-
sented. The vertical dotted lines
indicate weekly demipopula-
tions. The growth curves of cells
pooled from BFU-E– (green cir-
cles) and CFU-GM (red circles)–
derived colonies obtained from
cultures of normal mice (dashed
lines) and grown in parallel un-
der the same conditions de-
scribed above are also presented
as controls. The results are pre-
sented as the mean ( SD) of at
least three separate experiments.
FACS®  analysis for double ex-
pression of c-kit/CD34 (dot
plots) and Fc RI (histograms)
of CFU-EMkMc–derived cells
grown for 2 wk in suspension
culture (F) or on a fibroblast un-
derlayer (G) is shown. The cells
analyzed for Fc RI expression
had been gated as c-kit . For
convenience, only staining with
an irrelevant antibody is shown
for the Fc RI (dotted line) anal-
ysis. The c-kit   CD34   cells
present in G were separated by
FACS® and identified as contam-
inating fibroblasts. Similar results
were obtained in three additional
experiments.T
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normal (Fig. 1). On the other hand, high numbers of apop-
totic (TUNEL ; Fig. 4) precursor cells were detected in
tissues. It is possible that mutant mast cell precursors, as
mutant BMMC in culture, are unable to progress in their
maturation process and therefore activate an apoptotic pro-
gram. Adult GATA-1low mice maintain normal hemoglo-
bin and hematocrit as increased apoptosis observed at the
pro-erythroblasts level is counter balanced by high output
from the progenitor cell compartment (38, 39). Because in
the case of the erythroblasts, apoptosis is a direct conse-
quence of reduced GATA-1 expression (57), we suggest
here that GATA-1 is also involved in preventing death of
mast cell precursors.
The mature mast cells identified in connective tissue and
peritoneal lavage exhibit altered morphology that includes
large size, abnormal chromatin organization, and the pres-
ence of heterogeneously sized cytoplasmic granules (Fig. 2).
In addition, they expressed lower levels of Fc RI on their
surface and did not expressed MC-CPA (Fig. 3). These
findings are superficially reminiscent of abnormalities in
megakaryocyte maturation in the absence of GATA-1.
Therefore, we considered whether mast cell maturation is
blocked in the GATA-1low mice. In both semisolid cultures
and under BMMC-specific culture conditions, cells with
the profile of mast cell precursors (c-kithigh, CD34 ) were
detected as early as day 7 of culture of mutant cells com-
pared with 21 d in cultures of normal cells. Furthermore,
maturation of mutant cells was incomplete. Cells with al-
cian blue  metachromatic granules were not seen (Figs.
6, 8, and unpublished data). Additionally, GATA-1low
BMMC expressed lower levels of FC RI (Figs. 6, F and G,
and 7 A), released less [3H]serotonin after IgE- IgE stimu-
lation (Fig. 6 B) than normal BMMCs and did not express
MC-CPA (Fig. 7), which is the only mast cell–specific pro-
tease whose expression has been demonstrated to be under
GATA-1 control (32).
The similarities between the defects at the level of the
mast cell lineage and those observed in E and Mk cells sug-
gest but do not prove that the impaired mast cell differenti-
ation observed in the GATA-1low mice was the direct con-
sequence of a decreased GATA-1 expression in the cells of
this lineage. The GATA-1low animals compensate for the
defective hemopoiesis induced by the mutation by estab-
lishing a complex homeostatic mechanism that includes in-
Figure 7. BMMCs obtained from marrow of GATA-1low mice express
lower levels of Fc RI and MC-CPA and release less [3H]serotonin after
IgE- IgE stimulation than the normal cells. (A) FACS® analysis for the
expression of c-kit and Fc RI of BMMC obtained after 21 d of culture
under BMMC-specific conditions from normal mice and their GATA-1low
littermates are presented on the top and bottom panels, as indicated. Dot
plots for side scatter and c-kit expression and histograms for Fc RI ex-
pression of the c-kithigh gated cells are presented on the left and right, re-
spectively. Negative controls were represented by cells labeled with an
irrelevant isotype-matched antibody and for convenience are only pre-
sented for the Fc RI analysis. The results are representative of those ob-
tained in five separate experiments (each one started with cells harvested
from a different animal). (B) Level of serotonin (as cpm/105 cells) released
upon IgE- IgE stimulation by BMMC obtained after 21 d of culture un-
der specific culture conditions from GATA-1low mice (gray bars) and their
normal littermates (open bars). Positive and negative controls were repre-
sented by cells stimulated with IgE alone, medium plus  IgE, and me-
dium, human serum albumin, DNP, and Ionomycin, as indicated. The
levels of total serotonin that had been incorporated by the cells was mea-
sured by lysing the BMMC in Triton X-100. The results are presented as
the mean ( SD) of at least five separate experiments performed in dupli-
cate. (C) Semiquantitative RT-PCR analysis for the expression of  2 mi-
croglobulin ( 2-MG), GATA-1, GATA-2, MITF, MMCP6, MMCP7,
and MC-CPA genes in cells obtained after 21 d under BMMC-specific
culture conditions. Each product was amplified for an increasing number
of cycles (20, 25, 30, and 35), as indicated by the triangle on the top of the
panel. Similar results were obtained in two additional experiments.T
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creased growth factor gene expression (such as TGF-  and
platelet-derived growth factor) in the marrow microenvi-
ronment (40) and extensive extramedullary hemopoiesis in
the spleen (39). It remained possible that the alterations in
the mast cell differentiation pathway observed in these ani-
mals might be secondary to the mutation itself and the con-
sequence of the alterations observed in the microenviron-
ment. Although homogeneous, and therefore deprived of
accessory cells BMMC populations obtained from the mu-
tant mice did not progress properly along the differentia-
tion pathway even when cultured for an extensive period
of time ( 45 d) under highly specific culture conditions, it
could be argued that such a lack of differentiation was the
result of an in vivo priming by “nonpermissive” growth
factor stimulation. To determine if the abnormal differenti-
ation we observed in vitro was due to insufficient expres-
sion of GATA-1, we transduced GATA-1low mast cells
with a retrovirus harboring GATA-1 cDNA. After infec-
tion, full mast cell differentiation was restored. Thus, the
defects we describe in GATA-1low mast cells in vitro result
from lower than normal GATA-1 expression. Whether
cells entirely lacking GATA-1 would differ in phenotype is
under study.
In conclusion, mice with a mutation in the upstream en-
hancer and promoter of the GATA-1 gene exhibit a com-
plex phenotype that includes impaired mast cell differentia-
tion. From our findings we infer that GATA-1 has a critical
role in the proper differentiation of mast cells. In some re-
spects this requirement mimics the role of GATA-1 in both
E and Mk. The recent report that targeted deletion of the
Figure 8. Infection of GATA-
1low  BMMC with the PGK-
GATA-1 retrovirus increases the
level of GATA-1 expression and
restores in vitro maturation po-
tential. (A and B) GATA-1–spe-
cific immunofluorescent stain-
ing of BMMC either before or
17 d after their coculture with
the PGK-GATA-1–producing
cell line, as indicated. Cell nuclei
are counterstained with DAPI.
(C and D) Alcian blue staining of
the same cells shown above.
Toluidine blue staining of repre-
sentative cells are presented in
the inserts.  100 in all of the
cases. (E) Immunophenotype of
day 7 BMMC before infection
and 17 d after the 48-h coculture
with either NIH 3T3 (Mock-
inf.) or the PGK-GATA-1–pro-
ducing cell line (GATA-1 inf.).
Day 7 BMMC were immu-
nophenotyped with TER-119/
SCA-1 whereas cocultured
BMMC were immunopheno-
typed with c-Kit/Sca-1. (F)
Semiquantitative RT-PCR anal-
ysis for the expression of  2 mi-
croglobulin ( 2-MG, positive
control), GATA-1, GATA-2,
MITF, MMCP6, and MMCP7
genes in cells obtained after 7 d
under BMMC-specific culture
conditions (before infection) or
17 d after the BMMC had been
cocultured with either NIH 3T3
(Mock inf.) or the PGK-GATA-
1–producing cell line (GATA-1
inf.; the same cells as presented
above). Each product was ampli-
fied for an increasing number of
cycles (20, 25, 30, and 35), as in-
dicated by the triangle on the
top of the panel. Similar results
were obtained in two additional
experiments.T
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high affinity binding site in the GATA-1 promoter leads to
selective loss of the eosinophil lineage in vivo (26) and our
current data suggest that GATA-1 function is important in
the control of inflammation and allergic reactions.
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